Evidence map›Paper›PMID 38073641›Full record

ArticleFrontiers in neurology2023

Evaluation of taVNS for extreme environments: an exploration study of health benefits and stress operationality.

Barbara Le Roy, Charles Martin-Krumm, Adèle Gille, Sandrine Jacob, Cécile Vigier, Sylvain Laborde, Damien Claverie, Stéphane Besnard, Marion Trousselard

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Barbara Le RoyStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Charles Martin-KrummStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Adèle GilleStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Sandrine JacobStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Cécile VigierStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Sylvain LabordeDepartment of Performance Psychology, Institute of Psychology, German Sport University Cologne, Cologne, Germany.
Damien ClaverieStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Stéphane BesnardVERT-EX, Caen, France.
Marion TrousselardStress Neurophysiology Unit, French Armed Forces Biomedical Research Institute, Brétigny-sur-Orge, France.
Centre National d'Études Spatiales · FRGerman Sport University Cologne · DEInstitut catholique de paris · FRService de Santé des Armées · FRUniversité de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Long-duration space missions will be a real challenge for maintaining astronauts' adaptability. Research on transcutaneous vagus nerve stimulation (taVNS) is expanding rapidly, and its modalities constitute a major research challenge. A growing number of reviews stress the need to validate biomarkers for monitoring effects to enhance our understanding of the processes by which taVNS acts. Heart rate variability (HRV) appears to be a relevant candidate that informs on the autonomic nervous system (ANS). This is a promising technique to minimize the pathogenic effects of such large-scale missions and thus might be a relevant countermeasure. This study aimed to investigate the impact of taVNS on cognitive, psychological, and physiological functioning, including ANS functioning, and the benefits of increasing the number of taVNS sessions. Method: A total of 44 healthy participants were randomly assigned to one of the two cross-over protocols: a single session protocol (one taVNS and one sham simulation) or a repeated session protocol (three taVNS and three sham simulations). Cognitive, psychological, and physiological measures were performed before (pre) and after (post) each intervention. Sleep monitoring was only recorded before the first and after the last intervention in each protocol. For the repeated session protocol only, participants were allocated to two groups according to their parasympathetic activation gain during the three interventions: high parasympathetic delta (HPd) and low parasympathetic delta (LPd). Results: Participants in the repeated session protocol increased their HRV, cognitive performance, and sleep efficiency. In particular, taVNS induced higher parasympathetic activation and cardiac flexibility compared to the sham simulation in the repeated session protocol. Nevertheless, the perception of stress may indicate a nocebo effect of the repeated session. The HPd profile had higher interoceptive awareness, HRV highlighted by non-linear measures, and cognitive performance, but presented a decrease in some indicators of sleep efficiency compared to the LPd profile. Conclusion: taVNS seems to induce positive health outcomes, especially when the stimulation is repeated three times per week. Our findings highlight the benefits of parasympathetic activation during taVNS on psychophysiological and cognitive functioning. Further research is needed to validate these results on a large sample, using longitudinal measures over several months. This intervention appears promising as a countermeasure to extreme missions and occupations.

Indexed as

adaptationcognitioncountermeasurehealthstresstaVNS

Identifiers

PMID38073641
PMCPMC10698866
OpenAlexW4388903554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.